US 11820773
Tricyclic compounds
granted A61KA61K31/519A61K31/675
Quick answer
US patent 11820773 (Tricyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/519, A61K31/675, A61K45/06, A61P